B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE-2 RESULTS

Detalles Bibliográficos
Autores principales: van de Donk, NWCJ, Delforge, M, Agha, M, Cohen, AD, Cohen, YC, Hillengass, J, Anguille, S, Kerre, T, Roeloffzen, W, Schecter, JM, De Braganca, KC, Varsos, H, Wang, L, Vogel, M, Zudaire, E, Corsale, C, Akram, M, Geng, D, Nesheiwat, T, Pacaud, L, Sonneveld, P, Zweegman, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Best Abstracts - Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012122/
http://dx.doi.org/10.1097/01.HS9.0000829568.10814.bc

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012122/
http://dx.doi.org/10.1097/01.HS9.0000829568.10814.bc

Ejemplares similares